Sponsor-Investigators

Angela DeMichele

TBCRC046

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (“PALAVY”)

Status

Cancer Types

Breast

Locations

Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Georgetown Lombardi Comprehensive Cancer Center, Illinois, Indiana, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Massachusetts, Penn Medicine Abramson Cancer Center, Pennsylvania, Tennessee, The University of Chicago Medicine Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Washington, Washington, D.C.